Trading in Novo Nordisk shares by board members, executives and associated persons on 14 November 2019

Bagsværd, Denmark, 15 November 2019 — This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons.
Further information

Company announcement No 68 / 2019
AttachmentCompany announcement No 68 / 2019